Literature DB >> 9645475

A synthetic human Agouti-related protein-(83-132)-NH2 fragment is a potent inhibitor of melanocortin receptor function.

J M Quillan1, W Sadée, E T Wei, C Jimenez, L Ji, J K Chang.   

Abstract

Chemical synthesis of Agouti proteins - Agouti and Agouti-related proteins - is complicated by their large size and by multiple cysteine residues located in the carboxyl terminal regions. Three human Agouti-related protein (AGRP) fragments, two of which correspond to a proposed endoprotease cleavage site between amino acids 82 and 83, were synthesized and tested for anti-melanotropic activity using Xenopus laevis dermal melanophores. Amino-terminal fragments AGRP(25-51) and (54-82) were devoid of significant antagonist activity, whereas the amidated carboxyl-terminal AGRP fragment (83-132)-NH2 was potently active with an inhibitory equilibrium dissociation constant (Ki) of 0.7 nM. The ability to synthesize functionally active AGRP should help unravel its role in the central nervous system and its unusual properties with respect to interaction with the melanocortin family of G-protein coupled receptors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9645475     DOI: 10.1016/s0014-5793(98)00487-6

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  12 in total

Review 1.  Neuronal control of energy homeostasis.

Authors:  Qian Gao; Tamas L Horvath
Journal:  FEBS Lett       Date:  2007-12-03       Impact factor: 4.124

2.  Incorporation of Agouti-Related Protein (AgRP) Human Single Nucleotide Polymorphisms (SNPs) in the AgRP-Derived Macrocyclic Scaffold c[Pro-Arg-Phe-Phe-Asn-Ala-Phe-dPro] Decreases Melanocortin-4 Receptor Antagonist Potency and Results in the Discovery of Melanocortin-5 Receptor Antagonists.

Authors:  Zoe M Koerperich; Mark D Ericson; Katie T Freeman; Robert C Speth; Irina D Pogozheva; Henry I Mosberg; Carrie Haskell-Luevano
Journal:  J Med Chem       Date:  2020-01-06       Impact factor: 7.446

3.  Activation of melanocortin receptors in the intermediolateral cell column of the upper thoracic cord elicits tachycardia in the rat.

Authors:  Masamitsu Iwasa; Kazumi Kawabe; Hreday N Sapru
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-07-05       Impact factor: 4.733

4.  Structural and molecular evolutionary analysis of Agouti and Agouti-related proteins.

Authors:  Pilgrim J Jackson; Nick R Douglas; Biaoxin Chai; Jonathan Binkley; Arend Sidow; Gregory S Barsh; Glenn L Millhauser
Journal:  Chem Biol       Date:  2006-12

Review 5.  Melanocortin control of energy balance: evidence from rodent models.

Authors:  Bart C De Jonghe; Matthew R Hayes; Kendra K Bence
Journal:  Cell Mol Life Sci       Date:  2011-05-08       Impact factor: 9.261

6.  Effects of melanocortin receptor activation and blockade on ethanol intake: a possible role for the melanocortin-4 receptor.

Authors:  Montserrat Navarro; Inmaculada Cubero; Airu S Chen; Howard Y Chen; Darin J Knapp; George R Breese; Donald J Marsh; Todd E Thiele
Journal:  Alcohol Clin Exp Res       Date:  2005-06       Impact factor: 3.455

7.  An agouti mutation lacking the basic domain induces yellow pigmentation but not obesity in transgenic mice.

Authors:  R J Miltenberger; R L Mynatt; B D Bruce; W O Wilkison; R P Woychik; E J Michaud
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

Review 8.  Biased signaling at neural melanocortin receptors in regulation of energy homeostasis.

Authors:  Li-Kun Yang; Ya-Xiong Tao
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-04-19       Impact factor: 5.187

Review 9.  The role of the Agouti-Related Protein in energy balance regulation.

Authors:  O Ilnytska; G Argyropoulos
Journal:  Cell Mol Life Sci       Date:  2008-09       Impact factor: 9.261

Review 10.  60 YEARS OF POMC: Regulation of feeding and energy homeostasis by α-MSH.

Authors:  Erica J P Anderson; Isin Çakir; Sheridan J Carrington; Roger D Cone; Masoud Ghamari-Langroudi; Taneisha Gillyard; Luis E Gimenez; Michael J Litt
Journal:  J Mol Endocrinol       Date:  2016-03-03       Impact factor: 5.098

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.